• A hallmark of essential hypertension is an anomalous vascular tone due to the increase in intracellular Ca 2+ ([Ca 2+ ] i ) and/or Ca 2+ sensitivity in vascular smooth muscle. Down-regulation of K + channels together with increased Ca V 1.2 channel function has been proposed as one pathogenic mechanism.
• A hallmark of essential hypertension is an anomalous vascular tone due to the increase in intracellular Ca 2+ ([Ca 2+ ] i ) and/or Ca 2+ sensitivity in vascular smooth muscle. Down-regulation of K + channels together with increased Ca V 1.2 channel function has been proposed as one pathogenic mechanism.
• Using a mouse model of essential hypertension (BPH line), we found a decrease in the global smooth muscle Ca 2+ influx due to fewer Ca V 1.2 channels. However, these Ca V 1.2 channels are hyperactive, allowing a larger local Ca 2+ influx at rest that triggers an increased Ca 2+ release from intracellular stores (sparks).
• Large conductance, Ca 2+ -activated K + (BK) channels of BPH myocytes show reduced Ca 2+ sensitivity, so that its activation by the increased [Ca 2+ ] i is impaired.
• Our results suggest that changes in the molecular composition of both Ca V 1.2 and BK channels could explain vascular dysfunction during hypertension in BPH mice.
Abstract Hypertension is a clinical syndrome characterized by increased arterial tone. Although the mechanisms are varied, the generally accepted view is that increased Ca V 1.2 channel function is a common feature of this pathological condition. Here, we investigated the mechanisms underlying vascular dysfunction in a mouse model of genetic hypertension. Contrary to expectation, we found that whole-cell Ca V 1.2 currents (I Ca ) were lower in hypertensive (BPH line) than normotensive (BPN line) myocytes. However, local Ca V 1.2 sparklet activity was higher in BPH cells, suggesting that the relatively low I Ca in these cells was produced by a few hyperactive Ca V 1.2 channels. Furthermore, our data suggest that while the lower expression of the pore-forming α 1c subunit of Ca V 1.2 currents underlies the lower I Ca in BPH myocytes, the increased sparklet activity was due to a different composition in the auxiliary subunits of the Ca V 1.2 complexes. I Ca currents in BPN cells were produced by channels composed of α 1c /α 2 δ/β 3 subunits, while in BPH myocytes currents were probably generated by the opening of channels formed by α 1c /α 2 δ/β 2 subunits. In addition, Ca 2+ sparks evoked large conductance, Ca 2+ -activated K + (BK) currents of lower magnitude in BPH than in BPN myocytes, because BK channels were less sensitive to Ca 2+ . Our data are consistent with a model in which a decrease in the global number of Ca V 1.2 currents coexist with the existence of a subpopulation of highly active channels that dominate the resting
Introduction
Arterial myocytes contract in response to increases in intravascular pressure. The cellular and molecular mechanisms of this myogenic response, in particular the identity of the mechanosensor and the transduction pathway leading to changes in vessel diameter, remain poorly understood. Candidates to initiate the myogenic response include non-selective cation channels such as TRPC6 and TRPM4 (Welsh et al. 2002; Earley et al. 2004; Spassova et al. 2006) , G-protein coupled receptors (Schnitzler et al. 2008; Kauffenstein et al. 2012 ) and activation of several integrins (Martinez-Lemus et al. 2005) . However, regardless of the molecular nature of the sensor/transducer, vascular smooth muscle cell (VSMC) depolarization and a rise in intracellular calcium are well established as cornerstones of the myogenic response. Membrane depolarization activates sarcolemmal voltage-gated Ca V 1.2 channels, allowing a local elevation in intracellular Ca 2+ ([Ca 2+ ] i ) (Harder et al. 1987; Fleischmann et al. 1994; Rubart et al. 1996; Jaggar et al. 1998) . The influx of Ca 2+ via a single Ca V 1.2 channel or channel cluster can be optically detected in the form of a 'Ca V 1.2 sparklet' (Navedo et al. 2005; Amberg et al. 2007) . The simultaneous activation of multiple Ca V 1.2 sparklets induces a cell-wide increase in [Ca 2+ ] i that activates myosin light chain kinase and thus triggers contraction. The actions of the stretch activated channels and Ca V 1.2 channels on arterial myocyte membrane potential and [Ca 2+ ] i are opposed by three types of K + channels: the large conductance, Ca 2+ -activated K + (BK) channels, inwardly rectifying K + (K ir ) channels and voltage-gated K + (K v ) channels (Nelson & Quayle, 1995; Jackson, 2000; Moreno-Dominguez et al. 2009; Tajada et al. 2012) . BK currents are activated by Ca 2+ sparks caused by the opening of a small cluster of ryanodine receptors (RyRs) located in the sarcoplasmic reticulum (SR). Activation of BK, K v and K ir channels hyperpolarizes smooth muscle, which decreases Ca V 1.2 channel activity, Ca 2+ influx and [Ca 2+ ] i , and thus causes relaxation. Essential hypertension involves a gradual, sustained increase in total peripheral resistance caused by an increased vascular tone. The mechanisms underlying this pathological change in vascular function have been the subject of intense investigation. The generally accepted view is that down-regulation of K V and K IR channels and up-regulation of Ca V 1.2 channels are early events in the development of vascular dysfunction during hypertension (Martens & Gelband, 1996; Cox et al. 2001; Weston et al. 2010; Tajada et al. 2012) . On the basis of these data a model has been proposed in which decreased K + channel function depolarizes arterial smooth muscle. The combination of membrane depolarization and higher Ca V 1.2 channel expression conspires to generate pathologically high levels of Ca V 1.2 activity and consequently Ca 2+ influx, [Ca 2+ ] i , contraction and vasoconstriction. This chain of events culminates in a Ca 2+ -dependent increase in peripheral vascular resistance that contributes to the development of hypertension (Lozinskaya & Cox, 1997; Pesic et al. 2004) .
In this study, we tested this model using a mouse model of genetic hypertension. These mice were obtained by phenotypic selection from natural variants. Starting from a mixture of an eight-way cross of unrelated, inbred normotensive mice, three inbred lines of mice with low (BPL/1J), high (BPH/2J) and normal (BPN/3J) blood pressure were developed, and maintained with inbreeding (Schlager & Sides, 1997) . Here we use BPH mice (for blood pressure high) and their normotensive controls (BPN). We tested the hypothesis that this increased vascular reactivity is caused by changes in the molecular composition and function of Ca V 1.2 and BK channels in arterial myocytes. Consistent with this hypothesis, we found that whole-cell Ca V 1.2 currents (I Ca ) in BPN cells were produced by channels composed of α 1c /α 2 δ/β 3 subunits, while in BPH myocytes currents were probably generated by the opening of channels formed by α 1c /α 2 δ/β 2 subunits. Similarly, expression of the accessory β 1 subunit of BK channels is lower in BPH than in BPN myocytes. These changes have important functional consequences. In BPH myocytes, a small number of Ca V 1.2 channels account for the majority of Ca 2+ influx into these cells. Thus, although spatially averaged Ca 2+ influx via Ca V 1.2 channels is lower, local Ca 2+ sparklet activity is higher in BPH than in BPN myocytes. Furthermore, loss of the BKβ 1 subunit in BPH myocytes rendered BK channels incapable of responding to the large Ca 2+ sparks produced in these cells. This leads to increased vascular tone. Our data support a new model in which increases in local Ca 2+ signals resulting from alterations in the molecular composition of Ca V 1.2 and BK channels cause vascular dysfunction during hypertension.
Methods

Isolation of vascular smooth muscle cells
Colonies of BPN and BPH mice (Jackson Laboratories, Bar Harbor, ME, USA) were housed in the animal facility of the School of Medicine of Valladolid, under temperature-controlled conditions (21
• C) and with unlimited access to water and food. All animal protocols were approved by the Institutional Care and Use Committee of the University of Valladolid, and are in accordance with the European Community guiding principles in the care and use of animals.
Mice under isofluorane anaesthesia (5% at 2.5 l min
O 2 ) were killed by decapitation. We dissociated VSMCs from mesenteric arteries as previously described (Moreno-Dominguez et al. 2009 ). Briefly, the protocol uses a smooth muscle dissociation solution (SMDS) with the following constituents (in mM): NaCl, 145; KCl, 4.2; KH 2 PO 4 , 0.6; MgCl 2 , 1.2; Hepes, 10; glucose, 11; pH 7.4 (adjusted with NaOH). Segments of third-order mesenteric arteries were carefully dissected out of BPH and BPN mice and cleaned from adipose, connective and endothelial tissues. Arteries were either frozen (−80 • C) for ulterior RNA extraction or kept in ice-cold SMDS and cut into small segments. These segments were then placed in SMDS to which 0.4-0.6 mg ml −1 papain (Worthington, Lakewood, NJ, USA), 1 mg ml −1 bovine serum albumin (BSA; Sigma, St Louis, MO, USA) and 1 mg ml −1 1,4-dithioerythritol (DTE; Sigma) had been added and incubated in it for 9-15 min at 37
• C. This was followed by a second 12-16 min incubation in SMDS with 10 μM Ca 2+ , 0.4-0.8 mg ml −1 collagenase F (Sigma) and 1 mg ml −1 BSA. After rinsing the arteries twice with SMDS (10 μM Ca 2+ ), single cells were obtained by gentle trituration with a wide-bore glass pipette. Cells were maintained at 4
• C until used, typically 1-6 h after isolation.
Real-time PCR and Western blot analysis
RNA was extracted from approximately 30-40 secondand third-order mesenteric arteries obtained from 5-6 mice. After careful dissection and cleaning of adipose and connective tissues, endothelium was removed by perfusing the arterial lumen for 10 min with a 0.1% Triton X-100 solution at a pressure of 80 mmHg. Arteries were then opened longitudinally and the inner surface of the arteries was scraped manually with a plastic, 20 μl pipette tip. This minimized the possible contamination of VSMCs with other cell types, as previously demonstrated (Cidad et al. 2010) . After endothelium removal, arteries were homogenized in a Precellys 24 homogenizator (Bertin Tecnologies, Montigny-le-Bretonneux, France) using ceramic beads (CK 14). Total RNA was isolated using the TRIzol reagent as per the manufacturer's instructions (Invitrogen, Life Technologies, Carlsbad, CA, USA). After DNAse I (Ambion, Austin, TX, USA) treatment, 500-750 ng of RNA was reverse transcribed with MuLvRT (2.5 u μl −1 ) in the presence of 1 u μl
RNAse inhibitor, 2.5 μM random hexamers, 1× PCR buffer, 5 mM MgCl 2 and 4 mM mixed dNTPs at 42
• C for 60 min, to get cDNA (RT+). All reagents were from Applied Biosystems. Real-time PCR was performed with inventoried TaqMan R expression assays (Applied Biosystems, Foster City, CA, USA) using either a Rotor-Gene RG 3000 (Corbett Life Science, Qiagen, Valencia, CA, USA) thermocycler (for α and β 1 subunits of BK) or TaqMan Low Density Arrays and an ABI Prism 7900HT sequence detection system (Applied Biosystems) at the Parque Científico de Madrid (Madrid, Spain). Data were analysed using the threshold cycle (Ct) relative quantification method ( Ct) (Livak & Schmittgen, 2001) . Expression data of genes were normalized to the level of ribosomal RNA 18S or GADPH transcript. The relative abundance of the genes was calculated from 2 (− Ct ) , where Ct = Ct transcript of interest − Ct 18S or GADPH . Differences between hypertensive and normotensive VSMCs were calculated from 2 (− Ct ) , where Ct = Ct (BPH) -Ct (BPN) . For Western blot analysis, protein extraction was performed using a previously described method (Johnson et al. 2009 ) using 40 arteries from 3-4 animals. Immunoblots were performed as described elsewhere (Tajada et al. 2012) using Ca V 1.2 (75-053, 1:1000; Neuromab, Davis, CA, Biotechnology Inc., USA), α 2 δ (SC-271697, 1:500; Santa Cruz, CA, USA) or β 2 (SC81890, 1:200; Santa Cruz) antibodies. Data for 3-5 experiments using different samples were quantified with densitometric analysis of the bands (Quantity-One software, Bio-Rad, Hercules, CA, USA) using β-actin as loading control.
Electrophysiological methods
Whole-cell calcium currents were recorded at room temperature in isolated myocytes (or in transfected HEK cells) using the whole cell patch clamp configuration. Inward Ba Whole-cell currents were recorded using an Axopatch 200 patch-clamp amplifier, filtered at 2 kHz (−3 dB, four-pole Bessel filter), and sampled at 10 kHz. Recordings were digitized with a Digidata 1322A interface, driven by CLAMPEX 10 software (Axon Instruments, Molecular Devices, Sunnyvale, CA, USA).
Spontaneous BK currents were measured using the whole-cell patch clamp technique in the amphotericin B (300 μg ml −1 ) perforated patch configuration with the gap-free acquisition mode at −40 mV. Cells were continuously superfused with BK external solution containing (mM): 130 NaCl, 5 KCl, 1 MgCl 2 , 2 CaCl 2 , 10 Hepes and 10 glucose (pH 7.4 with NaOH). We analysed BK currents with an amplitude ≥6 pA, which based on the unitary current of BK channels at −40 mV (≈2 pA) , requires the simultaneous opening of at least three BK channels. The composition of the internal solution was (in mM): 10 NaCl, 110 potassium aspartate, 30 KCl, 1 MgCl 2 , 10 Hepes and 0.5 EGTA (pH 7.3 with KOH).
Inside-out recordings of BK single channel currents were carried out with a pipette solution containing (in mM): 125 KCl, 5 EGTA and 10 Hepes (pH 7.2 with KOH). After patch excision, the bath solution was switched to a solution of identical composition to that of the pipette but containing different amounts of CaCl 2 to get a free [Ca 2+ ] of 1, 5.5 or 10 μM. To obtain 100 μM free Ca 2+ , HEDTA instead of EGTA was used as Ca 2+ buffer. Total Ca 2+ was calculated using the Maxchelator software (C. Patton, Stanford University). Titrated stock solutions of CaCl 2 and EGTA (HEDTA) were used to minimize errors due to impurities of EGTA (HEDTA) and hydration of CaCl 2 . Single channel analysis was performed with PCLAMP software. Single-channel amplitudes and open probabilities were measured from amplitude histograms generated with FETCHAN. Open probabilities were expressed as NP o , where N represents the number of single channels present in the patch, and P o is the open probability of a single channel. The number of BK channels per patch was estimated from patches held at +80 mV in the presence of 100 μM Ca 2+ , which maximizes the open probability (P o ) of these channels.
Imaging of Ca
2+ sparklets and sparks Ca 2+ sparklet images were acquired using a throughthe-lens total internal reflectance fluorescence (TIRF) microscope built around an inverted Olympus IX-71 microscope equipped with an Olympus PlanApo TIRF (60×, NA = 1.49) oil immersion lens and an Andor iXON 597 EMCCD camera. Images were acquired at 100 Hz using TILL Image software. Cells were continuously superfused with a solution with the following constituents (in mM): 140 NaCl, 5 KCl, 1 MgCl 2 , 10 glucose and 10 Hepes, adjusted to pH 7.4. During experiments, this solution was exchanged for a solution containing a similar composition, except that KCl was substituted for CsCl, NaCl was substituted by N -methyl-D-glucamine (NMDG), CaCl 2 was 20 mM and 1 μmol l −1 thapsigargin was added to eliminate Ca 2+ release from intracellular stores. To monitor [Ca 2+ ] i , cells were patch-clamped under the whole-cell configuration using pipettes filled with a solution composed of (in mM): 87 caesium aspartate, 20 CsCl, 1 MgCl 2 , 5 MgATP, 10 EGTA, 10 Hepes and 0.2 fluo-5F (F14221; Invitrogen) adjusted to pH 7.2 with CsOH. Excitation of fluo-5F was achieved with a 488 nm solid state argon laser. Excitation and emission light was separated with the appropriate set of filters (Navedo et al. 2005) .
Background-subtracted fluorescence signals were converted to concentration units using the 'F max ' equation (Maravall et al. 2000) :
where F is fluorescence, F max is the fluorescence intensity of fluo-5F in the presence of a saturating free Ca 2+ concentration, K d is the dissociation constant of the fluorescence indicator used (1280 nmol l −1 ) and R f is the ratio of F max to the fluorescence intensity of fluo-5F in a solution where the Ca 2+ concentration is nominally 0 (F min ). K d and R f values for fluo-5F were determined in vitro. F max was determined at the end of experiments by exposing cells to a solution to which the Ca 2+ ionophore ionomycin (10 μM) and 20 mM external Ca 2+ had been added. Ca 2+ sparklets were detected and analysed as previously described (Navedo et al. 2005 sparklets are similar to those used by other investigators (Cheng et al. 1999; Demuro & Parker, 2004; Navedo et al. 2005) . Analogous to single-channel data analysis, the activity of Ca 2+ sparklets is determined by calculating the 'nP s ' of each sparklet site, where n is the number of quantal levels and P s is the probability that a quantal Ca 2+ sparklet event is active.
Imaging of Ca 2+ sparks was performed on cells loaded with the fluorescent Ca 2+ indicator fluo-4-AM (F14201; Invitrogen). VSMCs were loaded with 3 μM fluo 4-AM for 15 min at room temperature in the perfusion chamber.
Fluorescence was recorded using a livescan swept field confocal system (Nikon) coupled to a Nikon TE300 inverted microscope equipped with a Nikon 60× water immersion lens (NA = 1.4; Nikon, Melville, NY, USA). Ca 2+ sparks were imaged using the line-scan mode of the confocal microscope. Images were analysed using custom software written in IDL language (Research Systems, Boulder, CO, USA). Ca 2+ sparks were identified using a computer algorithm similar to that used in sparklets records. Images were normalized by dividing the fluorescence intensity of each pixel (F) by the average resting fluorescence intensity (F 0 ) of a confocal image to generate an F/F 0 image.
Culture and transfection of HEK293 cells
HEK293 cells were maintained in Dulbeco's modified Eagle's medium (DMEM) supplemented with 10% fetal bovine serum (Gibco, Paisley, UK), 100 U ml −1 penicillin, 100 μg ml −1 streptomycin, 0.25 μg ml −1 amphotericin B and 2 mM L-glutamine. Cells were grown as a monolayer to confluences up to 80% in a 35 mm Petri dish prior to transfection. Transient transfections were performed using lipofectamine 2000 (Invitrogen) according to the manufacturer's instructions. Cells were transfected with plasmids encoding Ca V 1.2 (1 μg), green fluorescent protein (GFP, 0.2 μg), and α 2 δ-1, β 2 or β 3 subunits (molar ratio Cav 1.2 /α 2 δ-1/β x 1:2:2). Ca V 1.2, α 2 δ-1, β 2 and β 3 plasmids were provided by Dr A. Castellano (Instituto de Biomedicina de Sevilla, IBIS, Universidad de Sevilla, Spain).
Results
Higher Ca V 1.2 sparklet activity and density in BPH than in BPN myocytes
We used TIRF microscopy to image Ca V 1.2 sparklets in BPN and BPN arterial myocytes. Figure 1A shows TIRF images and the time course of [Ca 2+ ] i in several sites within two representative myocytes. Upward deflections in the [Ca 2+ ] i records indicate Ca 2+ influx events in these sites. Ca V 1.2 sparklet density was approximately 1.6-fold higher in BPH than in BPN myocytes (Fig. 1B) . Amplitude histograms of Ca V 1.2 sparklets in BPN and BPH cells are shown in Fig. 1C . The data were fit with the sum of six (BPN) or seven (BPH) Gaussian functions. The quantal unit of Ca 2+ influx was 40 nM for BPN and BPH Ca V 1.2 sparklets, suggesting that the amplitude of the elementary event was similar in normotensive and hypertensive cells. Note, however, that the frequency of multiquantal events was higher in BPH than in BPN cells, suggesting a higher probability of coincidental Ca V 1.2 channel openings in BPH than in BPN cells. The distribution of Ca V 1.2 sparklet activity (nP s ) was bimodal (Fig. 1D) . The mean nP s values for the low activity sites were similar in BPN and BPH myocytes (0.063 ± 0.015 and 0.079 ± 0.012, respectively). However, high activity sites had nP s values of 0.47 ± 0.07 in BPN and 0.93 ± 0.11 in BPH cells (P < 0.02). Ca V 1.2 sparklet duration followed a double exponential distribution (Fig. 1E) . The time constants of the exponential fits were longer for BPH (24 ± 2.7 and 168 ± 13 ms) than for BPN sparklets (14 ± 4.2 and 94 ± 10 ms).
Together, these Ca V 1.2 sparklet data suggest that local Ca 2+ influx activity is higher in BPH than in BPN myocytes. This is due to higher Ca V 1.2 sparklet density and activity due to a higher frequency of longer Ca V 1.2 sparklet events in BPH than in BPN myocytes.
Lower I Ca in BPH than in BPN myocytes
A testable prediction of the local Ca V 1.2 sparklet data above is that Ca V 1.2 currents (I Ca ) are larger in BPH than in BPN myocytes. To do this, we used the patch-clamp technique in its whole-cell configuration. Ca V 1.2 currents were evoked by a 50 ms voltage step from the holding potential of −80 mV to potentials ranging from −70 to +70 mV using 10 mM Ba 2+ as the charge carrier. The average I-V relationships obtained from 60 BPN and 47 BPH myocytes are shown in Fig. 2A . Records from representative BPN and BPH myocytes are also shown in the figure. Surprisingly, we found that I Ca was larger in BPN than in BPH cells (at +10 mV, BPN = 10.27 ± 0.58 pA pF −1 vs. BPH = 5.83 ± 0.37 pA pF −1 ). This difference was also apparent when whole currents were recorded under the perforated patch configuration (at +10 mV, BPN = 4.96 ± 0.52 pA pF −1 vs. BPH = 2.50 ± 0.28 pA pF −1 ). The currents evoked by this protocol were blocked in the same proportion in BPN and BPH myocytes with nifedipine (1 μM), confirming that they were produced by Ca V 1.2 channels and suggesting that differences in current density can be explained by differences in Ca V 1.2 channel activity (Fig. 2B) .
In combination with the Ca V 1.2 sparklet data above, these I Ca data suggest that while the local Ca activity at a specific site is higher in BPH than in BPN myocytes, the spatially averaged Ca 2+ flux is lower in the hypertensive than in the normotensive cells. 
where N is the number of functional channels, P o is the open probability and i Ca is the amplitude of the current produced by the opening of a single Ca V 1.2 channel. Our sparklet data suggest that i Ca is similar in BPN and BPH myocytes (Fig. 1C ). Thus, we tested the hypothesis that N is higher in BPN than in BPH myocytes. The dihydropyridine BayK is a selective activator of Ca V 1.2 channels in VSMCs (Moosmang et al. 2003 ) that increases its P o to ≈ 1. Thus, if BPN and BPH cells have similar N , then BayK should equalize I Ca in these cells. Figure 3A shows average I-V relationships obtained before and after the application of BayK in BPN and BPH cells. A set of representative I Ca records is also shown in the figure. Although BayK increased the amplitude of the I Ca evoked by depolarization in BPN and BPH cells, it did not equalize the amplitude of the current in these cells (at −10 mV, BPN = 15.55 ± 1.21 pA pF −1 vs. BPH = 11.00 ± 1.17 pA pF −1 ). Similarly, we found that 'tail' I Ca values were larger in BPN than in BPH at most voltages examined under control conditions and in the presence of BayK (Fig. 3B) . The voltage dependence of tail currents reflects the voltage dependence of P o . As expected, BayK shifted the curve to the left, and this effect was similar in BPN and BPH myocytes. However, the increase in maximal current was significantly larger in BPH myocytes (5.72 ± 0.65-fold in BPH vs. 3.51 ± 0.50-fold in BPN, These I Ca data are consistent with the hypothesis that the number of functional Ca V 1.2 channels (i.e. N ) is higher in BPN than in BPH myocytes, which contributes to larger I Ca in normotensive than in hypertensive cells. spark amplitude was larger in BPH (453 ± 12.8 nM) than in BPN (261 ± 8.4 nM) myocytes (Fig. 4B) . However, spontaneous transient outward currents (STOCs) elicited by the activation of BK channels were smaller in BPH myocytes (Fig. 4C) . BK current amplitude was 10.55 ± 0.36 pA in BPH and 13.60 ± 0.43 pA in BPN myocytes (Fig. 4D) . These findings are consistent with the view that high local Ca V 1.2 sparklet activity in BPH myocytes translates into larger Ca 2+ spark amplitude in these cells. Furthermore, these data suggest that local Ca 2+ influx is a major determinant of SR Ca 2+ release in arterial smooth muscle. However, the larger Ca 2+ sparks seem to be uncoupled from BK channel activation in BPH cells.
The Ca 2+ sensitivity of BK channels is lower in BPH than in BPN myocytes
Potential mechanisms for lower BK current amplitude in BPH myocytes, in spite of larger Ca 2+ sparks, include a reduced number of BK channels in BPH cells, a lower Ca 2+ sensitivity of these channels in BPH than in BPN myocytes or a combination of these two mechanisms. To test these hypotheses, we recorded BK channel currents from inside-out patches at various voltages and Ca 2+ concentrations on the cytosolic side of the channels. An example of BK channel currents recorded at +40 mV from patches excised from BPN and BPH myocytes at several Ca 2+ concentrations (1, 5.5, 10 and 100 μM) is shown in Fig. 5A . The activity (NP o ) of BK channels in these patches over a wider range of potentials is illustrated in Fig. 5B . Average data of half activation voltages obtained in membrane patches from BPN and BPH cells at the Ca 2+ concentrations tested are shown in Fig. 5C . The inset shows also maximal NP o values (100 μM Ca 2+ , +80 mV). These data indicate that BPN myocytes have both a higher BK channel density and a higher Ca 2+ sensitivity than BPH myocytes, and are consistent with the observation of a decrease of BK α and β 1 subunit mRNA expression in BPH myocyes (Fig. 5D) .
Together with the Ca 2+ spark data, these data suggest that smaller STOCs in BPH than in BPN cells are due to a decrease in Ca 2+ sensitivity of BK channels during the development of hypertension. The decrease in Ca 2+ sensitivity in hypertensive cells is such that even larger Ca 2+ sparks cannot compensate for the decrease in Ca 2+ sensitivity.
Changes in the molecular composition of Ca V 1.2 channels during the development of hypertension
We examined whether differences in Ca V 1.2 channel activity between BPH and BPN myocytes were due to changes in the expression of accessory subunits using a multipronged strategy involving pharmacological, electrophysiological and biochemical approaches. Gabapentin (GBP) is a drug that binds to the α 2 δ subunit of Ca V 1.2 channels (Davies et al. 2007) . Since elevation in the expression of the α 2 δ-1 subunit has been reported during hypertension (Bannister et al. 2012) , we investigated the effects of GBP on I Ca in BPN and BPH myocytes. Application of 100 μM GBP induced an increase in I Ca (Fig. 6A) , both in BPN and in BPH myocytes, although the effect was much larger in BPH cells. The actions of GBP on I Ca were voltage independent (data not shown), reversible and reproducible. As a control, we examined the effects of the reducing agent dithiothreitol (DTT, 2 mM), which cleaves the disulphide bridge that binds the α 2 and the δ subunits, eliminating the binding site of GBP (Marais et al. 2001; Fig. 6B) . Note that after the application of DTT, GBP fails to increase I Ca , suggesting that GBP is acting on α 2 δ. We explored in detail the different response to GBP in BPN and BPH myocytes by characterizing the GBP concentration-I Ca response curves (Fig. 6C, left panel) . While the relationship between GBP and I Ca was bell-shaped in BPN cells, in BPH myocytes it was sigmoidal. To determine whether the different GBP response could reflect a different composition of auxiliary subunits in the Ca v 1.2 channel complex, similar experiments were performed in HEK cells transfected with different combinations of Ca v 1.2 auxiliary subunits (Fig.  6C, right panel) . HEK cells expressing the α 1C or α 1C and β 2 subunits of the channel did not respond to GBP, suggesting that the actions of the drug are not directly on these subunits of the channel. Rather, GBP increased I Ca only in cells expressing α 1C and α 2 δ-1. However, as in BPN and BPH myocytes, the concentration-response curves for cells expressing α 1C /α 2 δ-1/β 2 or α 1C /α 2 δ-1/β 3 were significantly different. The concentration-response curve of cells expressing β 3 and β 2 were bell-shaped and sigmoidal, respectively. These data suggest that the differences in the response to GBP between BPN and BPH mice can be due to a different proportion of β 2 subunits, and they are consistent with the view that the dominant molecular combination giving rise to BPH I Ca is α 1C /α 2 δ/β 2 subunits, while in BPN these currents are produced by channels formed of α 1C /α 2 δ/β 3 or α 1C /α 2 δ subunits.
To support this observation, we determined the level of mRNA and protein expression of different subunits of the Ca v 1.2 channel complex in BPN and BPH arteries. Figure 7A shows the results of real-time mRNA analysis of pore-forming and accessory Ca V 1.2 channel subunits. At the mRNA level, the α 2 δ-1, β 2 and β 3 auxiliary subunits are the more abundant in BPN myocytes (Fig. 7A , left panel). When mRNA expression was analysed in BPH myocytes (Fig. 7A, right panel) , we found differences in the expression of only α 1C , α 2 δ-3 and β 2 subunits. Not all these differences in mRNA translated into differences in protein expression (Fig. 7B) . α 1C and α 2 δ-1 protein levels correlated with mRNA levels in BPN and BPH myocytes. Consistent with the I Ca data above, α 1C protein expression was about 20% higher in BPN than in BPH arteries. Interestingly, in spite of the lower level expression of mRNA, and in agreement with the GBP data, β 2 protein expression was higher in BPH than in BPN myocytes.
Discussion
Our data support a new model in which changes in the molecular composition of Ca V 1.2 and BK channels alter local Ca 2+ signalling in arterial smooth muscle during essential hypertension (Fig. 8) . A key feature of this model is that Ca 2+ influx into hypertensive myocytes is dominated by a small group of Ca V 1.2 channels with a disproportionately high level of activity. Differences in local Ca V 1.2 channel activity between BPN and BPH myocytes are probably due to disparity in the ancillary subunits associated with these channels. In addition, myocytes from BPH mice present also a lower expression of BK β 1 subunits, which lowers their Ca 2+ sensitivity and renders them insensitive to their physiological activators: Ca
2+
sparks.
An important finding in this study is that I Ca was lower in hypertensive than in normotensive myocytes. The lower I Ca can result from the expression of fewer functional channels as well as a lower P o and/or i Ca of Ca V 1.2 channels. Although we did not record currents from single Ca V 1.2 channels, our observation that the amplitude of elementary Ca V 1.2 sparklets was similar in BPN and BPH cells suggests that changes in i Ca did not contribute to differences in I Ca between these cells. Rather, our electrophysiological (i.e. tail currents in the presence (Tajada et al. 2012) . Even with this difference in membrane potential, the predicted I Ca at −35 mV for BPH myocytes is ∼75% of that predicted for BPN cells. Of interest, although BPH myocytes have a lower global I Ca , pressure myography data obtained in equivalent BPN and BPH mesenteric arteries show that the active pressure-induced vasoconstriction and hence the myogenic tone were larger in BPH arteries (Tajada et al. 2012) . From these data, we propose that in spite of a decrease in the global number of Ca V 1.2 channels, the increased vascular tone characteristic of hypertension can be supported by a subpopulation of highly active channels that dominate the resting Ca 2+ influx. This subpopulation, together with changes in other conductances (such as BK channels and Kir channels), can determine the more depolarized resting E m and the increased reactivity of depolarized resting membrane potential mesenteric arteries. This complex interplay can become even more intricate if we consider the contribution of endothelial cell function to vascular reactivity. Although here we are studying isolated VSMCs, it has been shown that the mechanisms involving endothelial cell Ca 2+ events (leading to hyperpolarization and dilation) are dependent on intraluminal pressure (Bagher et al. 2012) , revealing a physiological role for myo-endothelial junctions that awaits further characterization in hypertensive vessels.
Our data are at odds with other studies investigating I Ca in other animal models of essential hypertension (e.g. SHR, Dahl salt-sensitive rats) that have found that even short-term exposure to high intravascular pressures appears to upregulate the α 1C subunit and the number of functional Ca V 1. 
subunits in BPN and BPH VSMCs
A, the left graph shows the relative abundance of the principal (α 1C ) and the accessory subunits of L-type Ca 2+ channels in BPN mesenteric myocytes, relative to the mRNA levels of RP18S, which was used as housekeeping gene. On the right, mRNA expression levels in BPH arteries were calculated using BPN expression levels as calibrator, so that only genes whose expression changes are shown in the figure. In this way, a value of 0 indicates no change, negative values indicate decreased expression and positive values increased expression relative to BPN. Each data point was obtained from quadruplicate determinations from at least three different samples. B, representative Western blots illustrating expression of the α 1C subunit, and the accessory subunits α 2 δ-1 and β 2 in BPN and BPH lysates. Blots were cut at 50 kDa to allow probing for β-actin as a loading control. The lower panels show the densitometric analyses of several experiments in each case (α 1C n = 6, α 2 δ-1 n = 5 and β 2 n = 4).
J Physiol 00.00 Cox, 1997; Martens & Gelband, 1996; Simard et al. 1998; Pesic et al. 2004) . In two of these studies, it was suggested that depolarization per se increases α 1C subunit expression in VSMCs from small arteries, suggesting that a chronic increase in intravascular pressure both activates existing Ca V 1.2 channels and increases the number of channels in VSMCs during the progression of hypertension (Pesic et al. 2004; Sonkusare et al. 2006) . However, it is important to note that increased Ca V 1.2 channel expression is not consistently found in all animal models of hypertension. For example, I Ca density has been reported to increase in young SHR, when blood pressure values are normal, but the difference disappears in old, hypertensive animals (Ohya et al. 1993) . Also, in SHR rats, and in spite of the finding of an increased Ca V 1.2 channel function, a lower level of Ca V 1.2 expression has been reported (Hermsmeyer et al. 1995) . In combination with our data, this study suggests that increased global Ca 2+ influx (e.g. I Ca ) is not required for the genesis or the maintenance of the hypertensive phenotype.
However, the Ca V 1.2 channel is not homogeneous. Instead, subpopulations of Ca V 1.2 channels operate in a continuously high open probability mode, producing distinct sites of Ca 2+ sparklet activity (Navedo et al. 2005; Santana & Navedo, 2009 (Rothberg & Magleby, 2000) . Interestingly, the V 0.5 of BK currents from BPH myocytes is not different from BPN cells at 1 μM Ca 2+ , but it is significantly depolarized at higher [Ca 2+ ]. These differences are very similar to those reported when BK currents mediated by BK(α+β 1 ) or BKα alone are compared, since the V 0.5 values for BK(α+β 1 ) are higher than for BKα for [Ca 2+ ] ≥1 μM (Orio & Latorre, 2005; Orio et al. 2006) . According to these observations, BPN myocytes would have a large proportion of BK channels composed of α+β 1 , while BPH myocytes showed a Ca 2+ sensitivity closer to BK channels composed of α subunits alone.
Our findings raise an important question: how does a decrease in Ca V 1.2 channel activity translate into a higher activity of Ca 2+ sparklets in BPH VSMCs? Data presented in this paper strongly suggest that the answer Figure 8 . Schematic view of the possible differences between BPN and BPH myocytes BPH Ca v 1.2 spatial organization in bigger clusters increases local Ca +2 sparklet amplitude, which determines an increase in the activity of RyR channels and leads to bigger Ca 2+ sparks. Under normal conditions, Ca 2+ sparks activate BK channels, producing STOCs that lead to membrane hyperpolarization. However, the correlation between Ca 2+ sparks and STOCs is lost in BPH due to the reduced Ca 2+ sensitivity of BK channels. This difference can be attributed to the decreased expression of the BK β1 subunit in BPH cells, and leads to a reduction of the negative feedback exerted by BK channels on resting membrane potential, and hence to a membrane depolarization. The data presented here also suggest that the differences in the activity, the spatial distribution and the modulation of Ca v 1.2 could be determined, at least in part, by a different subunit composition.
to this question relates to a different expression of Ca V 1.2 auxiliary subunits in the VSMCs from BPH mice. Ca V 1.2 channels are hetero-oligomeric complexes, consisting of up to four proteins. The principal subunit is α 1 , localized in the membrane and forming the conductive pore. The other three (β, α 2 δ and γ) are auxiliary subunits that modulate channel expression and activity. Not all the modulatory subunits are necessarily present in each channel complex, and the multiple possible combinations is a source of great versatility in terms of regulating channel trafficking, channel gating or channel modulation by other signalling molecules (Davies et al. 2007; Buraei & Yang, 2010) . Changes in the expression of these auxiliary subunits have been already reported in the context of hypertension. In cerebral arteries of SHR rats, age-dependent development of hypertension is associated with an unequal elevation in α 2 δ-1 and α 1C mRNA and protein, with α 2 δ-1 increasing more than α 1C . The elevation in α 2 δ-1 expression promotes surface trafficking of Ca V 1.2 channels, leading to an increase in current density and a reduction in current inactivation that induces vasoconstriction (Bannister et al. 2012) . Changes in the expression of β 3 subunits have been also linked to calcium channel upregulation in mice made hypertensive by angiotensin II infusion (Kharade et al. 2013) . Similarly, studies on β 3 −/− mice have shown that VSMCs express fewer Ca V 1.2 channels compared with WT mice. This implies that β subunits contribute to the basal expression of Ca V 1.2 channels in VSMCs in vivo (Murakami et al. 2003) .
In this work, we have tested the hypothesis that the observed differences in global and local activity of Ca V 1.2 channels from BPH cells could be the consequence of changes in the composition of auxiliary subunits in the channel complexes. We have used GBP as a tool to explore the functional contribution of α 2 δ subunits to Ca V 1.2 channels in VSMCs. The comparison of GBP effects on native currents with the effects obtained on currents elicited in a heterologous expression system combining different subunit compositions has revealed interesting insights about the possible differences between BPN and BPH Ca V 1.2 channels. Although GBP binding to α 2 δ-1 and α 2 δ-2 subunits is well established (Marais et al. 2001; Dooley et al. 2007) , the acute effects of GBP on Ca 2+ currents are controversial. GBP has been shown to inhibit a variety of Ca 2+ currents, including L-, N-and P/Q-type (Cheng & Chiou, 2006) . However, other studies show no acute effect of GBP on Ca 2+ currents (Hendrich et al. 2008) . On the contrary, in our study, we found that GBP increased Ca V 1.2 channel currents, this effect being significantly different in BPH and BPN VSMCs.
Two indirect lines of evidence demonstrate that the effects of GBP on Ca V 1.2 channels are due to its specific binding to α 2 δ subunits. First, in HEK cells we could not see any effect of the drug in any Ca V 1.2 channel subunit combination in which the α 2 δ subunit was not present.
Second, when we explored the effect on the native currents, we demonstrate the loss of the effect upon removal of the α 2 subunit by treatment with DTT. DTT is a reducing agent that cleaves the α 2 δ accessory subunit by breaking the disulphide bridge that holds them together, eliminating the binding site of GBP from the Ca V 1.2 channel complex (Marais et al. 2001; Davies et al. 2007) .
The concentration-response relationship for the acute effect of GBP is biphasic in BPN VSMCs and in HEK cells co-expressing α 1/ α 2 δ-1 or α 1/ α 2 δ-1/β3 subunits, with a maximal effect at ∼10 μM. A biphasic relationship discloses a complex interaction, with low-dose positive effects and high-dose negative effects. The simplest model to explain such a relationship would require two different binding sites for the drug, and this is currently not supported by the literature, since only one binding site has been reported (Marais et al. 2001; Davies et al. 2006) . However, the reported K d is in the nanomolar range, and GBP concentrations used in those studies (up to 1 μM) would not reveal another possible binding site at higher concentrations. Nevertheless, the striking result in our work is that the biphasic relationship disappears in BPH VSMCs and in HEK cells co-expressing α 1/ α 2 δ-1/β 2 subunits, suggesting that the different response to GBP between BPN and BPH cells can be due to a different proportion of the β 2 subunits in the functional Ca V 1.2 channels. These results do not correlate with the β 2 subunit mRNA changes observed in BPN VSMCs, but are in good agreement with the differences in protein expression described by Western blots. Since β 3 and β 2 are the main β subunits expressed in VSMCs (Murakami et al. 2003) , our data are compatible with the hypothesis that Ca V 1.2 channels are mainly formed by α 1/ α 2 δ/β 3 complexes in BPN VSMCs and α 1/ α 2 δ/β 2 complexes in BPH VSMCs. The putative increase in the number of α 1/ α 2 δ/β 2 complexes in BPH cells could be responsible for the differences in the local activity of Ca V 1.2 channels in those cells. In this regard, it is known that the size and the plasma membrane density of Ca V 1.2 channel clusters depend significantly on the type of β subunit present in the complex (Kobrinsky et al. 2009) .
To conclude, hypertension may be regarded as a narrative involving increased VSMC contractility, elevated blood pressure and increased mortality. However, the story can be told in different ways through the involvement of different characters that change in subtle and varied ways with time to achieve the same result of increased contractility. It is therefore not surprising that we are still far from understanding how to change the end of the story and ensure longer patient survival. These changes are complex, but our study suggests that changes in local Ca 2+ signalling could play a critical role in the development of vascular dysfunction during hypertension. How these changes contribute individually to the hypertensive phenotype is unclear, but taken as a whole, the data presented in J Physiol 00.00 this study clearly demonstrate that changes have to be interpreted in a global context, and that all differences must be integrated to properly understand the phenotypic change.
